Evaluation of cross-sex hormonal treatment in transsexuals: experience of an unit of gender identity disorders;Valoración del tratamiento hormonal cruzado en transexuales: experiencia de una unidad de trastornos de identidad de género

Revista Internacional de Andrologia

Volumn 7, Issue 3, 2009, Pages 150-155

  Becerra Fernández, Antonio ^a,b   Pérez López, Gilberto ^a   Lucio, María Jesús ^a   Asenjo, Nuria ^a   Rodríguez Molina, José Miguel ^a,c   Fernández Serrano, María Jesús ^a   Izquierdo, Concepción ^a   Martín, Rosario ^a   Frenzi Rabito, María ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Activin; Cross sex hormonal treatment; Gonadotropin; Inhibin; Transgender

Indexed keywords

EID: 70350734695     PISSN: 1698031X     EISSN: 16980409     Source Type: Journal    
DOI: 10.1016/S1698-031X(09)72569-5     Document Type: Article

References (14)

1. Gooren L. Hormone treatment of the adult transsexual patient. Horm Res 64 Suppl 2 (2005) 31-36
2. Moore E., Wisniewski A., and Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88 (2003) 3467-3473
3. Sreekumaran Nair K., and Rizza Robert A. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355 (2006) 1647-1659
4. Gooren L., and Giltay E. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93 (2008) 19-25
5. Mikkelsen W., Dodge H., and Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am J Med 39 (1965) 242-251
6. Nicholls A., Snaith M.L., and Scott J.T. Effect of oestrogen therapy on plasma and urinary levels of uric acid. BMJ 1 (1973) 449-451
7. Yahyaoui R., Esteva I., and Haro-Mora J. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab 93 (2008) 2230-2233
8. Becerra-Fernández A., Lucio Pérez M.J., and Llopis Agelan J. Tratamiento hormonal de reasignación de sexo en España: nuestra experiencia en 236 casos. Rev Int Androl 5 (2007) 212-217
9. Elbers J.M., and Giltay E.J. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58 (2003) 562-571
10. Lips P., Asscheman H., and Uitewaal P. The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res 4 (1989) 657-662
11. Terry Y., Ameeta M., and Anazodo A. Role of gonadotropin-releasing hormone and human chorionic gonadotrophin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrin Metab 94 (2009) 780-785
12. Veldhuis J., and Keenan D. Testosterone supplementation in older male restrains Insuline-like factor's dose dependent feedback inhibition of pulsatile growth hormone secretion. J Clin Endocrinol Metab 94 (2009) 246-254
13. Mueller A., Gooren J., and Naton-Schotz A. Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. J Clin Endocrinol Metab 93 (2008) 1408-1411
14. Boepple P., Hayes F., Dwyer A., Raivio T., and Lee H. Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function. J Clin Endocrinol Metab 93 (2008) 1809-1814